Edel Del Barco Morillo
Overview
Explore the profile of Edel Del Barco Morillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Portillo E, Olivares-Hernandez A, Corral Gudino L, Felix L, Hernandez L, Dominguez L, et al.
Clin Transl Radiat Oncol
. 2025 Mar;
52:100930.
PMID: 40028423
Background: Metformin is an antidiabetic drug that has shown its benefit in increasing the effect of radiotherapy in the treatment of solid tumors in preclinical studies. The objective of this...
2.
Ospina A, Bolufer Nadal S, Campo-Canaveral de la Cruz J, Gonzalez Larriba J, Macia Vidueira I, Massuti Sureda B, et al.
Clin Transl Oncol
. 2024 Mar;
26(7):1647-1663.
PMID: 38530556
Introduction: Recent advances in the treatment of locally advanced NSCLC have led to changes in the standard of care for this disease. For the selection of the best approach strategy...
3.
Chinchilla-Tabora L, Carlos Montero J, Corchete L, Gonzalez-Morais I, Morillo E, Olivares-Hernandez A, et al.
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38396726
In the last few years, nivolumab has become the standard of care for advanced-stage lung cancer patients. Unfortunately, up to 60% of patients do not respond to this treatment. In...
4.
Candal-Pedreira C, Ruano-Ravina A, de Juan V, Cobo M, Trigo J, Rodriguez-Abreu D, et al.
Arch Bronconeumol
. 2023 Dec;
60(2):88-94.
PMID: 38160163
Introduction: The aim of this study was to analyze the clinical and genetic characteristics of young lung cancer cases, and to compare them with those of older cases. Methods: We...
5.
Candal-Pedreira C, Ruano-Ravina A, de Juan V, Cobo M, Trigo J, Carcereny E, et al.
ERJ Open Res
. 2023 Dec;
9(6).
PMID: 38076676
Objectives: The aim of the study was to ascertain the percentage of Spanish lung cancer cases that would fulfil the lung cancer screening inclusion criteria recommended by the United States...
6.
Rubio-Casadevall J, Cirauqui B, Martinez Trufero J, Plana Serrahima M, Garcia Castano A, Carral Maseda A, et al.
Front Oncol
. 2023 Aug;
13:1226939.
PMID: 37601652
Objectives: The aim of this study was to confirm the efficacy of the ERBITAX scheme (paclitaxel 80 mg/m weekly and cetuximab 400 mg/m loading dose, and then 250 mg/m weekly)...
7.
Roldan Ruiz J, Fuentes Gago M, Chinchilla Tabora L, Morais I, Sayagues J, Abad Hernandez M, et al.
Diagnostics (Basel)
. 2023 Jul;
13(14).
PMID: 37510091
In recent years, non-small cell lung cancer treatment has been revolutionized. tyrosine kinase inhibitors and our improved understanding of its alterations have driven new diagnostic strategies. Liquid biopsies have emerged...
8.
Hitt R, Mesia R, Lozano A, Iglesias Docampo L, Grau J, Taberna M, et al.
Oral Oncol
. 2022 Sep;
134:106087.
PMID: 36126605
Objectives: Concurrent chemoradiotherapy is the standard treatment for patients with unresectable, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN); induction chemotherapy (ICT) may provide survival benefits in...
9.
Brage E, Heras Benito M, Navalon Jimenez M, Tocino R, Morillo E, Sanchez E
Case Rep Oncol
. 2022 Mar;
15(1):91-98.
PMID: 35350807
Altered natremia is a common electrolyte disorder in clinical practice and a paraneoplastic manifestation. The syndrome of inappropriate antidiuretic hormone secretion is the first diagnostic suspicion in a patient with...
10.
Olivares-Hernandez A, Morillo E, Miramontes-Gonzalez J, Figuero-Perez L, Perez-Belmonte L, Martin-Vallejo J, et al.
Front Biosci (Landmark Ed)
. 2022 Mar;
27(3):88.
PMID: 35345320
Background: Determining predictive biomarkers for immune checkpoint inhibitors (ICIs) is a current challenge in oncology. Previous studies on non-small cell lung cancer (NSCLC) have shown how gene mutations are correlated...